AlphaOne Investment Services’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
RHJA
GT
AlphaOne Investment Services's SUPN Position: Q3 2019 in Review
AlphaOne Investment Services sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 32,300 shares — an estimated $1.07M sold.
AlphaOne Investment Services first reported a position in SUPN in Q4 2014 and held it in 19 quarters. The position peaked at $9.48M in Q2 2017. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.
- AlphaOne Investment Services reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
- AlphaOne Investment Services sold 32,300 Supernus Pharmaceuticals shares in Q3 2019, an estimated $1.07M.
- AlphaOne Investment Services first reported a position in Supernus Pharmaceuticals in Q4 2014 and held it in 19 quarters.
- AlphaOne Investment Services's Supernus Pharmaceuticals position peaked at $9.48M in Q2 2017.
- 243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.
Based on AlphaOne Investment Services's 13F filing for Q3 2019, filed 12 Nov 2019.